{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:16:50Z","timestamp":1785237410674,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jinhua Central Hospital Basic Research Special Scientific Research Fund Project","award":["No. JY2021-6-04"],"award-info":[{"award-number":["No. JY2021-6-04"]}]},{"name":"Jinhua Key Science and Technology Plan Project","award":["No. 2023-03-109"],"award-info":[{"award-number":["No. 2023-03-109"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01850-5","type":"journal-article","created":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T07:10:05Z","timestamp":1756019405000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic utility and clinical relevance of anti-MCV and anti-CCP antibodies in rheumatoid arthritis"],"prefix":"10.1007","volume":"25","author":[{"given":"Feng","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,24]]},"reference":[{"key":"1850_CR1","first-page":"171","volume":"129","author":"GS Firestein","year":"2018","unstructured":"Firestein GS. Pathogenesis of rheumatoid arthritis: the intersection of genetics and epigenetics. Trans Am Clin Climatol Assoc. 2018;129:171\u201382.","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"5","key":"1850_CR2","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.3390\/biomedicines11051262","volume":"11","author":"J Mitrovi\u0107","year":"2023","unstructured":"Mitrovi\u0107 J, Hrka\u010d S, Te\u010der J, et al. Pathogenesis of extraarticular manifestations in rheumatoid arthritis\u2014a comprehensive review. Biomedicines. 2023;11(5):1262. https:\/\/doi.org\/10.3390\/biomedicines11051262.","journal-title":"Biomedicines"},{"key":"1850_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24279-1","author":"H Yang","year":"2018","unstructured":"Yang H, Bian S, Chen H, et al. Clinical characteristics and risk factors for overlapping rheumatoid arthritis and Sj\u00f6gren\u2019s syndrome. Sci Rep. 2018. https:\/\/doi.org\/10.1038\/s41598-018-24279-1.","journal-title":"Sci Rep"},{"issue":"1","key":"1850_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2025.102036","volume":"39","author":"P Uke","year":"2025","unstructured":"Uke P, Maharaj A, Adebajo A. A review on the epidemiology of rheumatoid arthritis: an update and trends from current literature. Best Pract Res Clin Rheumatol. 2025;39(1): 102036. https:\/\/doi.org\/10.1016\/j.berh.2025.102036.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"1850_CR5","doi-asserted-by":"publisher","first-page":"404","DOI":"10.31138\/mjr.301223.eaf","volume":"34","author":"AI Venetsanopoulou","year":"2023","unstructured":"Venetsanopoulou AI, Alamanos Y, Voulgari PV, Drosos AA. Epidemiology and risk factors for rheumatoid arthritis development. MJR. 2023;34(4):404. https:\/\/doi.org\/10.31138\/mjr.301223.eaf.","journal-title":"MJR"},{"key":"1850_CR6","doi-asserted-by":"publisher","DOI":"10.26574\/maedica.2020.16.1.22","author":"G Jindal","year":"2021","unstructured":"Jindal G, Bansal S, Gupta N, Singh SK, Gahukar S, Kumar A. Comparison of ultrasonography and X-rays for the diagnosis of synovitis and bony erosions in small joints of hands in early rheumatoid arthritis: a prospective study. Maedica. 2021. https:\/\/doi.org\/10.26574\/maedica.2020.16.1.22.","journal-title":"Maedica"},{"issue":"1","key":"1850_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/annrheumdis-2018-213904","volume":"78","author":"T Diekhoff","year":"2019","unstructured":"Diekhoff T, Ulas ST, Poddubnyy D, et al. Ultra-low-dose CT detects synovitis in patients with suspected rheumatoid arthritis. Ann Rheum Dis. 2019;78(1):31\u20135. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213904.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1850_CR8","doi-asserted-by":"publisher","first-page":"105065","DOI":"10.1016\/j.jbspin.2020.07.014","volume":"88","author":"SC Brunet","year":"2021","unstructured":"Brunet SC, Finzel S, Engelke K, Boyd SK, Barnabe C, Manske SL. Bone changes in early inflammatory arthritis assessed with high-resolution peripheral quantitative computed tomography (HR-pQCT): a 12-month cohort study. Joint Bone Spine. 2021;88(1):105065. https:\/\/doi.org\/10.1016\/j.jbspin.2020.07.014.","journal-title":"Joint Bone Spine"},{"issue":"3","key":"1850_CR9","first-page":"234","volume":"62","author":"E Braschi","year":"2016","unstructured":"Braschi E, Shojania K, Allan GM. Anti-CCP: a truly helpful rheumatoid arthritis test? Can Fam Physician. 2016;62(3):234.","journal-title":"Can Fam Physician"},{"issue":"11","key":"1850_CR10","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/art.24827","volume":"61","author":"R Aggarwal","year":"2009","unstructured":"Aggarwal R, Liao K, Nair R, Ringold S, Costenbander KH. Anti\u2013citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis. Arthritis Rheum. 2009;61(11):1472\u201383. https:\/\/doi.org\/10.1002\/art.24827.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"1850_CR11","doi-asserted-by":"publisher","first-page":"693","DOI":"10.5694\/j.1326-5377.2009.tb02640.x","volume":"190","author":"SM Chatfield","year":"2009","unstructured":"Chatfield SM, Wicks IP, Sturgess AD, Roberts LJ. Anti-citrullinated peptide antibody: death of the rheumatoid factor? Med J Aust. 2009;190(12):693\u20135. https:\/\/doi.org\/10.5694\/j.1326-5377.2009.tb02640.x.","journal-title":"Med J Aust"},{"key":"1850_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.plabm.2024.e00420","volume":"41","author":"HA Nelson","year":"2024","unstructured":"Nelson HA, Banerjee D, Novis CL, Deane KD, Feser ML, Nandakumar V. A comparison of anti-cyclic citrullinated peptides (CCP3 and CCP3.1) autoantibody tests in rheumatoid arthritis. Pract Lab Med. 2024;41: e00420. https:\/\/doi.org\/10.1016\/j.plabm.2024.e00420.","journal-title":"Pract Lab Med"},{"issue":"6","key":"1850_CR13","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3899\/jrheum.080796","volume":"36","author":"X Liu","year":"2009","unstructured":"Liu X, Jia R, Zhao J, Li Z. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis. J Rheumatol. 2009;36(6):1136\u201342. https:\/\/doi.org\/10.3899\/jrheum.080796.","journal-title":"J Rheumatol"},{"key":"1850_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/ar2570","author":"P Nicaise Roland","year":"2008","unstructured":"Nicaise Roland P, Grootenboer Mignot S, Bruns A, et al. Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy. Arthritis Res Ther. 2008. https:\/\/doi.org\/10.1186\/ar2570.","journal-title":"Arthritis Res Ther"},{"key":"1850_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/285854","volume":"2012","author":"A Al-Shukaili","year":"2012","unstructured":"Al-Shukaili A, Al-Ghafri S, Al-Marhoobi S, Alkaabi J. Evaluation of anti-mutated citrullinated vimentin antibodies, anti-cyclic citrullinated peptide antibodies and rheumatoid factor in Omani patients with rheumatoid arthritis. Int J Rheumatol. 2012;2012:1\u20135. https:\/\/doi.org\/10.1155\/2012\/285854.","journal-title":"Int J Rheumatol"},{"issue":"1","key":"1850_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12016-007-8016-3","volume":"34","author":"H Poulsom","year":"2007","unstructured":"Poulsom H, Charles PJ. Antibodies to citrullinated vimentin are a specific and sensitive marker for the diagnosis of rheumatoid arthritis. Clin Rev Allergy Immunol. 2007;34(1):4\u201310. https:\/\/doi.org\/10.1007\/s12016-007-8016-3.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"1850_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/09674845.2019.1658425","volume":"77","author":"J Huang","year":"2019","unstructured":"Huang J, Zeng T, Zhang X, et al. Clinical diagnostic significance of 14\u20133-3\u03b7 protein, high-mobility group box-1, anti-cyclic citrullinated peptide antibodies, anti-mutated citrullinated vimentin antibodies and rheumatoid factor in rheumatoid arthritis. Br J Biomed Sci. 2019;77(1):19\u201323. https:\/\/doi.org\/10.1080\/09674845.2019.1658425.","journal-title":"Br J Biomed Sci"},{"issue":"7","key":"1850_CR18","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3390\/cells8070657","volume":"8","author":"F Carubbi","year":"2019","unstructured":"Carubbi F, Alunno A, Gerli R, Giacomelli R. Post-translational modifications of proteins: novel insights in the autoimmune response in rheumatoid arthritis. Cells. 2019;8(7):657. https:\/\/doi.org\/10.3390\/cells8070657.","journal-title":"Cells"},{"issue":"6","key":"1850_CR19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.5114\/reum.2020.101276","volume":"58","author":"M Ebrahimi-Rad","year":"2020","unstructured":"Ebrahimi-Rad M, Khatami S, Akhbari H, et al. Evaluation of autoantibodies against vimentin and \u03b1-enolase in rheumatoid arthritis patients. Reumatologia. 2020;58(6):350\u20136. https:\/\/doi.org\/10.5114\/reum.2020.101276.","journal-title":"Reumatologia"},{"key":"1850_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.119767","volume":"561","author":"P Karami","year":"2024","unstructured":"Karami P, Gholamin D, Fathi F, Afsar T, Johari-Ahar M. Anti-CCP biosensors in rheumatoid arthritis. Clin Chim Acta. 2024;561: 119767. https:\/\/doi.org\/10.1016\/j.cca.2024.119767.","journal-title":"Clin Chim Acta"},{"issue":"2","key":"1850_CR21","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12016-021-08890-1","volume":"63","author":"MV Sokolova","year":"2021","unstructured":"Sokolova MV, Schett G, Steffen U. Autoantibodies in rheumatoid arthritis: historical background and novel findings. Clin Rev Allergy Immunol. 2021;63(2):138\u201351. https:\/\/doi.org\/10.1007\/s12016-021-08890-1.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"11","key":"1850_CR22","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.autrev.2012.02.015","volume":"11","author":"E Bartoloni","year":"2012","unstructured":"Bartoloni E, Alunno A, Bistoni O, et al. Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature. Autoimmun Rev. 2012;11(11):815\u201320. https:\/\/doi.org\/10.1016\/j.autrev.2012.02.015.","journal-title":"Autoimmun Rev"},{"issue":"9","key":"1850_CR23","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2010;69(9):1580\u20138. https:\/\/doi.org\/10.1136\/ard.2010.138461.","journal-title":"Ann Rheum Dis"},{"key":"1850_CR24","doi-asserted-by":"publisher","unstructured":"https:\/\/doi.org\/10.19723\/j.issn.1671-167X.2024.06.005","DOI":"10.19723\/j.issn.1671-167X.2024.06.005"},{"issue":"1","key":"1850_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.55133\/eji.300111","volume":"30","author":"HS Mohammed","year":"2023","unstructured":"Mohammed HS, Ahmed GH, Tawfik NM, Sayed SK, Ahmed AS. Anti-mutated citrullinated vimentin antibodies in rheumatoid arthritis; diagnostic utility and association with deformities and disease activity. Egypt J Immunol. 2023;30(1):105\u201315.","journal-title":"Egypt J Immunol"},{"issue":"8","key":"1850_CR26","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.25122\/jml-2023-0158","volume":"16","author":"HAA Khudhair","year":"2023","unstructured":"Khudhair HAA. A study of the roles of some immunological biomarkers in the diagnosis of rheumatoid arthritis. JMedLife. 2023;16(8):1194\u2013200. https:\/\/doi.org\/10.25122\/jml-2023-0158.","journal-title":"JMedLife"},{"issue":"4","key":"1850_CR27","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.semarthrit.2018.03.011","volume":"48","author":"FM Kudaeva","year":"2019","unstructured":"Kudaeva FM, Speechley MR, Pope JE. A systematic review of viral exposures as a risk for rheumatoid arthritis. Semin Arthritis Rheum. 2019;48(4):587\u201396. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.03.011.","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"1850_CR28","doi-asserted-by":"publisher","first-page":"578","DOI":"10.55563\/clinexprheumatol\/gs3o43","volume":"39","author":"B Wahlin","year":"2021","unstructured":"Wahlin B, Fasth AER, Karp K, et al. Atherosclerosis in rheumatoid arthritis: associations between anti-cytomegalovirus IgG antibodies, CD4+CD28null T-cells, CD8+CD28null T-cells and intima-media thickness. Clin Exp Rheumatol. 2021;39(3):578\u201386. https:\/\/doi.org\/10.55563\/clinexprheumatol\/gs3o43.","journal-title":"Clin Exp Rheumatol"},{"key":"1850_CR29","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1136\/annrheumdis-2012-eular.519","volume":"71","author":"CR Vizioli","year":"2012","unstructured":"Vizioli CR, Viana V, Ribeiro AC, et al. AB0519 auto-antibody titers for monitoring rituximab therapy in rheumatoid arthritis. Ann Rheum Dis. 2012;71:667. https:\/\/doi.org\/10.1136\/annrheumdis-2012-eular.519.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1850_CR30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.63032\/IDQB5912","volume":"3","author":"SA Elsayed","year":"2024","unstructured":"Elsayed SA, Mohafez OM, Saif DS. Anti-mutated citrullinated vimentin antibodies as a biomarker for interstitial lung disease in patients withrheumatoid arthritis. ARP Rheumatol. 2024;3(4):295\u2013303.","journal-title":"ARP Rheumatol."},{"key":"1850_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/536050","volume":"2014","author":"L Gonzalez-Lopez","year":"2014","unstructured":"Gonzalez-Lopez L, Rocha-Mu\u00f1oz AD, Ponce-Guarneros M, et al. Anti-Cyclic citrullinated peptide (Anti-CCP) and anti-mutated citrullinated vimentin (Anti-MCV) relation with extra-articular manifestations in rheumatoid arthritis. J Immunol Res. 2014;2014: 2014:1\u201310. https:\/\/doi.org\/10.1155\/2014\/536050.","journal-title":"J Immunol Res"},{"issue":"12","key":"1850_CR32","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1136\/annrheumdis-2013-203510","volume":"72","author":"C Turesson","year":"2013","unstructured":"Turesson C, Mathsson L, Jacobsson LTH, Sturfelt G, R\u00f6nnelid J. Antibodies to modified citrullinated vimentin are associated with severe extra-articular manifestations in rheumatoid arthritis. Ann Rheum Dis. 2013;72(12):2047\u20138. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203510.","journal-title":"Ann Rheum Dis"},{"issue":"23","key":"1850_CR33","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1016\/j.febslet.2011.06.006","volume":"585","author":"AM Quirke","year":"2011","unstructured":"Quirke AM, Fisher BAC, Kinloch AJ, Venables PJ. Citrullination of autoantigens: upstream of TNF\u03b1 in the pathogenesis of rheumatoid arthritis. FEBS Lett. 2011;585(23):3681\u20138. https:\/\/doi.org\/10.1016\/j.febslet.2011.06.006.","journal-title":"FEBS Lett"},{"issue":"11","key":"1850_CR34","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1136\/annrheumdis-2019-215764","volume":"78","author":"RM Fleischmann","year":"2019","unstructured":"Fleischmann RM, Genovese MC, Enejosa JV, et al. Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response. Ann Rheum Dis. 2019;78(11):1454\u201362. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215764.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1850_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jbspin.2017.02.010","volume":"85","author":"M Scherlinger","year":"2018","unstructured":"Scherlinger M, Alain S, Richez C. Monitoring of Epstein-Barr virus (EBV)\/cytomegalovirus (CMV)\/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritis. Joint Bone Spine. 2018;85(2):259\u201360. https:\/\/doi.org\/10.1016\/j.jbspin.2017.02.010.","journal-title":"Joint Bone Spine"}],"updated-by":[{"DOI":"10.1007\/s10238-025-01891-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000}}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01850-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01850-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01850-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:49:05Z","timestamp":1764917345000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01850-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,24]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1850"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01850-5","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,24]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10238-025-01891-w","URL":"https:\/\/doi.org\/10.1007\/s10238-025-01891-w","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Clinical Ethics Committee of Jinhua Central Hospital (No. 2024-183).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"302"}}